Editors & Staff
Teodoro Pulvirenti, Executive Editor email@example.com
Teodoro (Teo) received his PhD from the Mario Negri Sud Institute in Italy. He then carried out his postdoctoral work in the lab of Alan Hall at Memorial Sloan Kettering Cancer Center, studying the role of Wnt signaling in cancer stem cells, and continued this line of research in the lab of Eric Holland at the same institution. Teo started his editorial career at The Journal of Experimental Medicine (JEM) in 2013. He then joined Nature Cell Biology as Senior Editor, and returned to JEM as Executive Editor in 2016.
Thiago Carvalho, Senior Scientific Editor firstname.lastname@example.org
Thiago received his PhD from Porto University working in the laboratory of Jocelyne Demengeot at the Gulbenkian Institute of Science, studying regulatory T cells. After a postdoc on marginal zone B cells with John Kearney at the University of Alabama, Birmingham, Thiago returned to the Gulbenkian, where he was Head of Graduate Studies. He joined The Journal of Experimental Medicine as a Scientific Editor in 2015. Thiago is also in charge of JEM Reviews and Perspectives.
Alejo Chorny, Senior Scientific Editor email@example.com
Alejo completed his PhD in cellular and molecular immunology at Consejo Superior de Investigaciones Cientificas in Granada, Spain. After postdoctoral work at the Icahn School of Medicine Mount Sinai with Andrea Cerutti studying marginal zone and mucosal B cell responses, he joined The Journal of Experimental Medicine as a Scientific Editor in 2015. Alejo is also in charge of JEM Collections and Insights.
Shachi Bhatt, Scientific Editor firstname.lastname@example.org
Shachi received her PhD in Anatomy and Cell Biology from University of Kansas Medical Center. She pursued her postdoctoral research in the lab of Paul Trainor at the Stowers Institute for Medical Research, where she studied the development of peripheral nervous and vascular systems, WNT/β-catenin signaling, and neural crest cell induction and differentiation. She joined The Journal of Experimental Medicine as a Scientific Editor in 2017.
Zhe Wang, Scientific Editor email@example.com
Zhe received his BS at Zhejiang University in China and then earned his PhD in the lab of Harm HogenEsch at Purdue University, examining the pathogenesis of autoimmune diseases. After postdoctoral work at the MD Anderson Cancer Center with Patrick Hwu studying host response to cancer immunotherapy using a high-throughput shRNA screening approach, he joined The Journal of Experimental Medicine as a Scientific Editor in 2016.
Editorial Board Co-Chairs
Carl Nathan, Editorial Board Co-Chair
Carl Nathan is an R.A. Rees Pritchett Professor of Microbiology and Professor and Chairman of Microbiology, Immunology, and Medicine at Weill Cornell Medical College. After studying and working at Harvard College, Harvard Medical School, Massachusetts General Hospital, the National Cancer Institute, and Yale, Carl was board certified in internal medicine and oncology but decided on full-time research. For the first 10 years, his lab was in Zanvil Cohn’s group at The Rockefeller University. He then moved to the medical college at Cornell, where he has served as founding director of the Tri-Institutional MD-PhD Program, Senior Associate Dean for Research, Acting Dean, and Chairman of the Department of Microbiology and Immunology. Nathan began studying neutrophils in high school. His interests grew to include macrophages, tumor cells, inflammation, tuberculosis, reactive oxygen intermediates, reactive nitrogen intermediates, immunology, biochemistry, and chemical biology. Carl joined the editorial board of The Journal of Experimental Medicine as an Assistant Editor in 1981, and has been an Academic Editor since 1988.
Michel Nussenzweig, Editorial Board Co-Chair
Michel Nussenzweig is a Sherman Fairchild Professor, Senior Physician, and a Howard Hughes Investigator at The Rockefeller University. Michel earned a PhD from The Rockefeller University for his work with Ralph Steinman on dendritic cells and an MD from NYU Medical School. Following training in medicine and infectious diseases at the Massachusetts General Hospital, he worked with Dr. Philip Leder in the Department of Genetics at Harvard Medical School on antibody genes. His laboratory focuses on understanding B cell and dendritic cell physiology. Michel became an Academic Editor of The Journal of Experimental Medicine in 1995.
Yasmine Belkaid, Editor
Yasmine Belkaid obtained her PhD in 1996 from the Pasteur Institute in France exploring innate immune responses to parasitic infections. After a postdoctoral fellowship at the National Institute of Allergy and Infectious Diseases (NIAID) in the US, she joined the Children’s Hospital Research Foundation in Cincinnati as an assistant professor. In 2005, she joined NIAID and was appointed Senior Scientist in 2008. She is currently the chief of the Mucosal Immunology Section and Director of the NIAID Microbiome initiative. Her work explores mechanisms that regulate host immune responses to microbes at barrier sites and revealed key roles for the microbiota and dietary factors in the maintenance of tissue immunity and homeostasis. Yasmine joined JEM as Academic Editor in 2017.
Jean-Laurent Casanova, Editor
Jean-Laurent Casanova is a Professor at The Rockefeller University, Howard Hughes Medical Institute Investigator, and Head of the St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch. He is also a Professor at the Necker Hospital for Sick Children, Paris Descartes University, where the Necker Branch of the Laboratory is located. Jean-Laurent received his PhD from the Pierre et Marie Curie Paris University in 1992 after being trained at the Pasteur Institute in Paris and the Ludwig Institute for Cancer Research in Lausanne. He received his MD in 1995 following medical studies and a residency in pediatrics in Paris. He then completed a clinical fellowship in the pediatric immunology−hematology unit of the Necker Hospital in Paris. In 1999 he was appointed a Professor of Pediatrics at Necker, where, with Laurent Abel, he cofounded and co-directed the Laboratory of Human Genetics of Infectious Diseases. He was recruited by the Rockefeller University in 2008. Work in his laboratory tests the hypothesis that severe infectious diseases may result from single-gene inborn errors of immunity. He has discovered genetic etiologies of various infectious diseases, including viral, bacterial, and fungal diseases. Jean-Laurent became an Academic Editor of The Journal of Experimental Medicine in 2006.
Douglas T. Fearon, Editor
Douglas Fearon is the Walter B. Wriston Professor of Pancreatic Cancer Research at the Weill Cornell Medical College and Professor at Cold Spring Harbor Laboratory. He is also Emeritus Sheila Joan Smith Professor of Immunology at the University of Cambridge. He obtained his MD and completed his training in internal medicine at the Johns Hopkins Medical School and did his postdoctoral fellowship in rheumatology and immunology at Harvard Medical School in the laboratory of K. Frank Austen. He has served on the faculties of Harvard Medical School, Johns Hopkins, and the University of Cambridge before his current appointments. He research interests have included the biochemistry and molecular biology of the complement system, signaling in B lymphocytes, the development of memory CD8+ T cells, and, most recently, the tumor microenvironment. Doug joined the editorial board of The Journal of Experimental Medicine in 1990 as an advisory editor and became an Academic Editor in 2015.
David Holtzman, Editor
David Holtzman received his BS and MD from Northwestern University followed by a Neurology residency at UCSF. He did post-doctoral research at UCSF and moved to Washington University in 1994 where he is currently Professor and Chair of Neurology, scientific director of the Hope Center for Neurological Disorders, and Associate Director of the Knight ADRC. Some of his lab’s accomplishments include showing in part how apoE4 contributes to AD, how synaptic activity and sleep affect amyloid-β (Aβ) levels dynamically in vivo, being involved in the development of the SILK technique to measure protein synthesis and clearance in the human CNS, developing a promising anti-Aβ antibody now in 3 phase III trials and an anti-tau antibody in clinical trials. He has received a number of honors including being a recipient of a Paul Beeson Physician Faculty Scholar award in Aging research, the Potamkin prize from the American Academy of Neurology for research on Alzheimer’s disease, the MetLife award for Alzheimer’s disease research, a MERIT award from the NIA, election to the National Academy of Medicine of the National Academy of Sciences, an alumni merit award from the Northwestern Feinberg School of Medicine, being appointed to the National Advisory council of the NINDS and the NIH council of councils, the Chancellor’s award for innovation and entrepreneurship and the Carl and Gerty Cori award from Washington University, and being elected Fellow of the AAAS. Holtzman has trained over 50 graduate students, post-doctoral fellows, and physician-scientists, many of whom have gone on to successful careers in academia and industry.
Susan Kaech, Editor
Susan Kaech, PhD, is currently Professor of Immunobiology in the Department of Immunobiology, Yale School of Medicine, New Haven, CT. Her laboratory aims to understand how memory T cells are generated during infection and vaccination and why, in some circumstances, an immunization fails to induce long-term T cell immunity. They are also learning how T cells are regulated in tumor microenvironments to better understand how their functions become suppressed as they infiltrate tumors in order to develop new methods of immunotherapy that enhance antitumor responses. Using several powerful model systems of infection or cancer in mice, they are elucidating mechanisms involved in the development of protective and long-lived memory T cells that form after acute infection or, conversely, of dysfunctional or “exhausted” T cells that form in tumors or during chronic viral infections. Their studies are aimed at identifying the signaling and metabolic pathways that regulate the differentiation of T cells in these different types of environments so that we can design new ways to optimize the formation of highly functional, protective memory T cells to fight infection and cancer. Susan joined JEM as Academic Editor in 2017.
Lewis L. Lanier, Editor
Lewis L. Lanier is an American Cancer Society Research Professor, a Professor and Vice Chair of the Department of Microbiology and Immunology, and Professor of the Cancer Research Institute at the University of California, San Francisco. Lewis received his PhD in microbiology and immunology from the University of North Carolina at Chapel Hill. After postdoctoral studies, first at the Lineberger Cancer Center at UNC Chapel Hill and then as a Damon Runyon−Walter Winchell Cancer Research Fellow at the University of New Mexico, he joined the Research & Development Department at the Becton Dickinson Monoclonal Center in Mountain View, California, advancing to Associate Director of Research, and was a Becton Dickinson Research Fellow. In 1990, he joined the DNAX Research Institute of Molecular and Cellular Biology in Palo Alto, California, where he advanced to Director of Immunobiology. In 1999, Lewis joined the faculty of UCSF. His research group studies natural killer (NK) cells, which recognize and eliminate cells that have become transformed or infected by viruses. Lewis has been an Academic Editor of The Journal of Experimental Medicine since 2008.
William A. (Bill) Muller, Editor
William A. Muller is the Magerstadt Professor and Chairman of the Department of Pathology at Northwestern University Feinberg School of Medicine. He received his PhD degree from The Rockefeller University and an MD degree from Cornell University Medical College. He did residency/postdoctoral fellowship training at the Massachusetts General Hospital and Brigham and Women’s Hospital in Boston before returning to Rockefeller and Cornell to set up his own laboratory. Bill was recruited to Northwestern in 2007. His research interests focus on the cellular and molecular biology of the inflammatory response, particularly from the perspective of the vascular endothelial cell. His laboratory focuses on leukocyte−endothelial cell interactions and the role of the endothelial cell in regulating inflammation with the aim of designing more selective antiinflammatory therapies. Bill has played several major leadership roles in the American Society for Investigative Pathology and the North American Vascular Biology Organization. He has been on the editorial board of The Journal of Experimental Medicine since 1993 and became an Academic Editor in 1996.
Anne O’Garra, Editor
Anne O'Garra is the head of the Division of Immunoregulation at the National Institute for Medical Research (NIMR), Mill Hill, London, UK. Anne obtained her PhD at the NIMR working on bacterial adhesion and then moved fields and joined the Division of Immunology at NIMR as a Postdoctoral Fellow, where she studied the role of cytokines in B cell growth and differentiation. Anne moved to California in 1987, where she spent 15 years at the DNAX Research Institute. There, Anne's laboratory delineated mechanisms for the development of discrete subsets of CD4+ T cells and showed that this is determined by a number of factors, including cytokines, dose and form of antigens, and the antigen-presenting cells. A major focus of her work has been on the mechanisms for induction of IL-10 and the function of this cytokine to regulate immune responses. In 2001 Anne formed the new Division of Immunoregulation at the NIMR to interface the divisions of immunology and infectious diseases, continuing research on immunoregulation, also with major emphasis on the immune response in tuberculosis in mouse models and in human disease.
Emmanuelle Passegué, Editor
Emmanuelle Passegué, PhD, is an Alumni Professor of Genetics and Development and Rehabilitation Medicine and the Director of the Columbia Stem Cell Initiative at Columbia University Medical Center. Before her recent move to Columbia University, Emmanuelle was Professor of Medicine in the Hematology/Oncology Division and the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at the University of California, San Francisco. She received her PhD from the University Paris XI in France and performed postdoctoral trainings with Dr. Erwin Wagner at the Institute for Molecular Pathology in Austria and Dr. Irv Weissman at Stanford University. Emmanuelle’s research interests focus on the biology of blood-forming hematopoietic stem cells (HSCs) in normal and deregulated contexts such as stress, malignancies, and aging. She has received numerous Scholar Awards from the American Society of Hematology, the Rita Allen Foundation, the California Institute for Regenerative Medicine, and the Lymphoma and Leukemia Society. Emmanuelle joined JEM as Academic Editor in 2017.
Alexander (Sasha) Rudensky, Editor
Alexander Rudensky is an HHMI Investigator and a member of the Department of Immunology at Memorial Sloan Kettering Cancer Center. Prior to his recent move to Sloan Kettering, he was Professor of Immunology at the University of Washington School of Medicine, Seattle, and Adjunct Professor at the A.N. Belozersky Institute of Physico-Chemical Biology, Moscow State University, Russia. Dr. Rudensky received his PhD degree from the Gabrichevsky Research Institute of Epidemiology and Microbiology, Moscow. After postdoctoral training at Yale University Medical School with Charles Janeway, he remained as an associate research scientist. Dr. Rudensky was a Searle Scholar and received a Pharmingen Investigator Award from the American Association of Immunologists.
Alexander Rudensky is studying the development of T lymphocytes, their function, and their role in the regulation of immune responses to infection and in the prevention of autoimmunity. His studies include investigation of the control of immune homeostasis by regulatory T cells and investigation of the molecular mechanisms instructing commitment of specialized T cell lineages.
Alan Sher, Editor Emeritus
Alan Sher is a Senior Investigator at the National Institute of Allergy and Infectious Diseases, NIH, where he heads the Laboratory of Parasitic Diseases. Alan obtained his PhD from the University of California, San Diego, for work done in the laboratory of Melvin Cohn, and he did postdoctoral training at the National Institute for Medical Research, Mill Hill, in the UK. He was a Research Associate and then Assistant Professor in the Department of Pathology at Harvard Medical School before joining the NIH. His group’s major interest has been in mechanisms of host resistance and immune regulation in parasitic and mycobacterial infections. Alan became an Academic Editor of The Journal of Experimental Medicine in 2007.
David Tuveson, Editor
David Tuveson is the Director of the Cold Spring Harbor Laboratory (CSHL) Cancer Center, the Roy J. Zuckerberg Professor of Cancer Research at CSHL, the head of the Lustgarten Foundation Pancreatic Cancer Research Laboratory at CSHL, and is also the Lustgarten Foundation’s Director of Research. Dr. Tuveson completed a bachelor's degree at MIT (Chemistry, 1987), the MD-PhD program at Johns Hopkins in 1994, an Internal Medicine residency at Brigham and Women's Hospital in 1997, and a Medical Oncology fellowship at Dana-Farber/Harvard in 2000. While at Dana-Farber, he co-developed Gleevec/Imatinib with George Demetri as a new treatment for patients with gastrointestinal stromal tumors (GIST). Dr Tuveson completed a postdoctoral fellowship with Tyler Jacks at MIT, where he developed several mouse cancer models and investigated GIST. He was appointed assistant Professor of Medicine at the University of Pennsylvania from 2002 to 2006, where his laboratory developed the ductal pancreatic cancer models. Dr. Tuveson moved in 2006 to the CRUK/Cambridge Research Institute at the University of Cambridge to establish a preclinical therapeutics laboratory and a pancreatic cancer clinical trials group. In Cambridge, his laboratory determined several mechanisms that contribute to drug resistance in pancreatic cancer, stimulating clinical trials in these areas. He was appointed Professor of Pancreatic Cancer Medicine at the University of Cambridge and Founder of the Pancreatic Cancer Centre. In 2012, Dr. Tuveson moved to Cold Spring Harbor Laboratory as Professor and director of the Cancer Therapeutics Program. His honors include the Rita Allen Foundation Scholar Award, the Waldenstrom Award (2014), the Hamdan Award (2016), and election to the American Society of Clinical Investigation (2016).
Consulting Biostatistical Editor
Xi Kathy Zhou, Consulting Biostatistical Editor
Xi Kathy Zhou is an Associate Professor of Biostatistics at Weill Cornell Medical College. She received her PhD degree in Statistics and Decision Sciences from Duke University. Her research interest is to develop and apply novel statistical methods to better design biological and clinical studies related to disease prevention, diagnosis and treatment and properly analyze data generated from such studies. Her methodological interest include Bayesian hierarchical models, model selection, model averaging, predictive modeling, and their applications to large complex datasets. She collaborates extensively with laboratory researchers and clinicians and has served as the Lead Biostatistician in clinical trials. Kathy became the Consulting Biostatistical Editor of The Journal of Experimental Medicine in 2016.
Brianna Caszatt, Senior Production Editor
Brianna has been at The Rockefeller University Press since 2008, working her way up from Copy Editor for The Journal of Cell Biology to Senior Production Editor for The Journal of Experimental Medicine and The Journal of General Physiology.
Sylvia Cuadrado, Managing Editor
Sylvia has worked at The Rockefeller University Press since 2005. She loves TV and happy hour.
Erinn A. Grady, Production Designer
Erinn has been with The Rockefeller University Press since 1998, starting out as Copy Editor for The Journal of Cell Biology. Prior to joining the Press, she spent many years working in academic (Boston University Science and Engineering Library), public (Boston Public Library), and law (O’Melveny & Myers, LLP) libraries. Erinn studied psychology and biology at Boston University.
Shauna O’Garro, Assistant Production Editor
Shauna graduated from Rutgers University with a BA in English. She started her career at The Rockefeller University Press as a Copy Editor at The Journal of Cell Biology. In 2007, she became Assistant Production Editor of The Journal of Experimental Medicine.
Rochelle Ritacco, Preflight Editor
Rochelle is responsible for the preparation of figures for RUP publication—checking production quality, conforming style, and clarity of presentation. She is a skilled digital artist with expertise in many media applications. Rochelle began freelancing at RUP in 2007 and shortly thereafter joined the staff. Prior to RUP, she assisted the campus photographer at Monmouth University. Rochelle received her BA in communications from Seton Hill University and has completed two certificate programs, Digital Art (BCC) and Filmmaking (NYU). She is on the board of the Belmar Art Council. Rochelle lives along the dazzling north Jersey shore with her husband and daughter.
Frederick W. Alt
K. Frank Austen
Michael J. Bevan
Christine A. Biron
Hal E. Broxmeyer
Robert L. Coffman
Daniel J. Cua
Myron I. Cybulsky
Riccardo Dalla Favera
Vincent A. Fischetti
Richard A. Flavell
Ronald N. Germain
Christopher A. Hunter
Vijay K. Kuchroo
Bart N. Lambrecht
Klaus F. Ley
James S. Malter
Sean J. Morrison
Benjamin G. Neel
John J. O'Shea
Paul H. Patterson
Gwendalyn J. Randolph
David L. Sacks
Matthew D. Scharff
Stephen P. Schoenberger
Robert A. Seder
Charles N. Serhan
Ethan M. Shevach
Roy L. Silverstein
Steven L. Teitelbaum
Kevin J. Tracey
Marcel R.M. van den Brink
Ulrich von Andrian
Harald von Boehmer
Christopher M. Walker
Raymond M. Welsh
E. John Wherry
Linda S. Wicker
Kristin A. Hogquist
Louis M. Staudt